Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

PaperCitations, authors & open-access status

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2,975 citations, 2018 year and bronze oa status.

2,975
Citations
2018
Year
bronze
OA Status

Related on ScholarIQ

Scott D. Solomon
Author
New England Journal of Medicine
Journal
Amyloidosis: Diagnosis, Treatment, Outcomes
Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Topic
Alzheimer's disease research and treatments
Topic
Skin and Cellular Biology Research
Topic
470M+ articles · free account